The Inhibitory Response to PI3K/AKT Pathway Inhibitors MK-2206 and Buparlisib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines

by Al-Ali, R., Ameziane, N., Bauer, P., Escobar, H.M, Junghanss, C., Kong, W., Krake, S., Lerch, M.M, Ma, Y., Parveen, A., Radefeldt, M., Sekora, A., Sender, S., Weiss, F.U, Zechner, D.
Published 2022

The Inhibitory Response to PI3K/AKT Pathway Inhibitors MK-2206 and Buparlisib Is Related to Genetic Differences in Pancreatic Ductal Adenocarcinoma Cell Lines

by Al-Ali, R., Ameziane, N., Bauer, P., Escobar, H.M, Junghanss, C., Kong, W., Krake, S., Lerch, M.M, Ma, Y., Parveen, A., Radefeldt, M., Sekora, A., Sender, S., Weiss, F.U, Zechner, D.
Published 2022